MedTrace Logo

A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

NCT00592111 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2015-12-23

No results posted yet for this study

Summary

Study Hypothesis: Clinical staging without laparotomy/splenectomy is adequate for children and young adults with Hodgkin's disease who receive chemotherapy as a component of treatment.

Conditions

  • Pediatric
  • Hodgkin's Disease

Interventions

DRUG

COPP/ABV

4 courses of COPP/ABV hybrid

DRUG

COPP/ABV

6 courses of COPP/ABV hybrid

DRUG

intensive chemo with concurrent growth factor

6 cycles (2 courses) of intensive chemotherapy with concurrent growth factor

Sponsors & Collaborators

Principal Investigators

  • Tanya Trippett, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-03-31
Primary Completion
1999-02-28
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00592111 on ClinicalTrials.gov